NEAR Protocol has partnered with SilentSwap to enable cross-network transactions across more than 30 blockchain networks. This integration is now live in SilentSwap's app and software development kit (SDK), allowing users to route transactions and connect liquidity seamlessly. SilentSwap's privacy technology also supports confidential transactions, enhancing security for users. This collaboration aims to improve interoperability and privacy in decentralized finance applications.
NEAR Protocol's integration with SilentSwap is presented here with a snapshot of the broader cryptocurrency market on Pluang. For readers following major cryptocurrencies, as of Oct 14, 2026 22:02 WIB, only 6 out of 50 major cryptocurrencies rose while 43 fell. Among notable movers, Polkadot (DOT) traded at Rp20.033 with a 1-day change of -5.99% and a typical hold time of 121 days, contrasting with MultiversX (EGLD) at Rp64.579, which saw a -5.64% change but had 100% buy order activity and a shorter hold time of 85 days. Filecoin (FIL) was priced at Rp19.578 with a -5.56% change and a hold time of 99 days.
Jefferies has maintained a Buy rating on Big Yellow Group despite recent stock declines, citing the company's strong fundamentals including freehold properties and solid cash flows. Activist investor Ancora, holding over 4% of shares, is pushing Big ...
Fastenal reported strong Q3 2026 earnings, beating analyst expectations with EPS of $0.35 and revenue of $2.46 billion. The company saw a 20% rise in net income to $401.6 million and a 15.5% increase in revenue driven by robust manufacturing demand, ...
Remittix announced the public launch of its RTX token on November 24, 2026, marking the end of its presale phase which raised over $32 million from 40,000 participants. The project is testing its PayFi platform, which enables crypto-to-fiat and fiat-...
The global microbiology testing market is projected to grow rapidly at a compound annual growth rate (CAGR) of approximately 9% from 2026 to 2034, reaching a market size of $13.7 billion by 2034. This growth is driven by the rising prevalence of infe...
H.C. Wainwright raised its price target for Alector from $5.00 to $8.00, maintaining a Buy rating due to progress in its neurodegenerative disease pipeline. Alector develops treatments for Alzheimer's and Parkinson's using its Brain Carrier platform ...
